Could a digital tool help sarcoma patients handle treatment side effects?
NCT ID NCT06211257
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a digital personalized care plan (ePCP) can help people with advanced sarcoma who are on chemotherapy. About 377 participants will either get the digital plan plus standard care, or standard care alone. The main goal is to see if the digital tool reduces severe side effects in the first three months of treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
digital personalized care plan (ePCP)
What this could lead to
If it works, this could improve how patients manage severe side effects from sarcoma treatment, making their experience less difficult.
What could go wrong
This is a non-drug intervention, so the benefit may be small or hard to measure. The trial is still recruiting and results are not yet available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
CHU Jean Minjoz
RECRUITINGBesançon, Bourgogne-Franche-Comté, 25000, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Poitiers
RECRUITINGPoitiers, New Aquitaine, 86021, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Eugène Marquis
NOT_YET_RECRUITINGRennes, Brittany Region, 35042, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Léon Bérard
RECRUITINGLyon, Auvergne-Rhône-Alpes, 69373, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Oscar Lambret
RECRUITINGLille, Hauts-de-France, 59020, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Centre Paul Strauss
RECRUITINGStrasbourg, Grand Est, 67033, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Gustave Roussy
RECRUITINGVillejuif, Île-de-France Region, 94800, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hôpital Pitié-Salpêtrière AP-HP
NOT_YET_RECRUITINGParis, Île-de-France Region, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut Claudius Regaud
WITHDRAWNToulouse, Occitanie, 31059, France
-
Institut de Cancérologie de Lorraine
NOT_YET_RECRUITINGVandœuvre-lès-Nancy, 54519, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Institut de Cancérologie de l'Ouest
RECRUITINGSaint-Herblain, Pays de la Loire Region, 44805, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact